{"id":"W64788256","doi":"","title":"Pazopanib: an orally administered multi-targeted tyrosine kinase inhibitor for locally advanced or metastatic renal cell carcinoma.","year":2011,"lang":"en","type":"article","venue":"PubMed","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pazopanib; Medicine; Renal cell carcinoma; Sorafenib; Sunitinib; Tyrosine-kinase inhibitor; Oncology; Adverse effect; Kidney cancer; Internal medicine; Clinical trial; Cancer; Pharmacology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001628642,0.0003779799,0.0003856911,0.0009278101,0.000114273,0.0003967368,0.0002542771,0.0003159691,0.004904875],"category_scores_gemma":[0.0002330612,0.00008055162,0.0002858799,0.00120637,0.0001400206,0.000334139,0.0001969939,0.000413245,0.002107718],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002605111,"about_ca_system_score_gemma":0.0003701979,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004366997,"about_ca_topic_score_gemma":0.0008448774,"domain_scores_codex":[0.999921,0.00001305503,0.0000101541,0.00001523295,0.00003042295,0.00001020322],"domain_scores_gemma":[0.9999474,0.00000958424,0.00002329194,0.000001166823,0.00001107893,0.000007460199],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0008187142,0.0001205465,0.0009817649,0.01155229,0.0001105589,0.001427788,0.00004201588,0.0003075887,0.01789491,0.0008316087,0.02729946,0.9386127],"study_design_scores_gemma":[0.0008897569,0.001648783,0.01060585,0.002528144,0.0006582786,0.01762461,0.00006128418,0.0005737869,0.01826074,0.000991832,0.9461173,0.0000396485],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.01559796,0.9574987,0.001631316,0.001810765,0.0007874377,0.0001718326,0.001385296,0.0002244221,0.0208923],"genre_scores_gemma":[0.1071639,0.8668258,0.003527168,0.002616917,0.001160272,0.0001519229,0.003806451,0.00002680276,0.01472082],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.004904875,"threshold_uncertainty_score":0.01640838,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09985080328074944,"score_gpt":0.2772050420670524,"score_spread":0.177354238786303,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}